Research and Reviews in the Fastlane 141

This study showed that while it’s feasible to acutely lower systolic blood pressure < 140 mm Hg, there’s no benefit to death or disability. Additionally, patients in the aggressive blood pressure treatment arm were more likely to have adverse renal events at 7 days. These results mirror those seen in the INTERACT-2 trial (prior to the statistical shenanigans used to spin the results positively). Based on the best available evidence, we can confidently say that it should not be standard care to aggressively drop blood pressure in these patients. Recommended by Anand Swaminathan Further reading The case of the differing perspectives (EM Nerd) Airway Boccio E, et al. Combining transtracheal catheter oxygenation and needle-based Seldinger cricothyrotomy into a single, sequential procedure. Am J Emerg Med 2015. PMID: 25791154 Can’t Intubate? Can’t Ventilate? Big problem! Remember the most important procedure may be the most simplistic – Transtracheal Ventilation. This paper, though, takes transtracheal ventilation one step further and may prove to be extremely valuable to you and your patient! Recommended by Sean M. Fox Further reading Can’t Intubate Can’t Ventilate (Pediatric EM Morsels) Emergency Medicine Zitek T, et al. The Effect of Nebulized Albuterol on Serum Lactate and Potassium in Healthy Subjects. Academic emergency medicine 2016. PMID: 26857949 This is a tiny study of healthy volunteers that reminds us that nebulized ...
Source: Life in the Fast Lane - Category: Emergency Medicine Authors: Tags: Airway Clinical Research Emergency Medicine Neurology Neurosurgery Pediatrics R&R in the FASTLANE Resuscitation critical care EBM Education literature recommendations research and reviews Source Type: blogs